OB-GYN 101
Pharmacy

Contents  ·  Introduction  ·  Learning Objectives  ·  Clinical Issues  ·  Procedures  ·  Library  ·  Pharmacy  ·  Lab  ·  Chest X-ray  ·  Ultrasound  ·  Videos  ·  Forms  ·  Progress Notes  ·  Facts Cards  ·  Students  ·  Search  ·  Feedback  ·  About Us

 

 

Acyclovir (Zovirax)

Category:

  • Antiviral

Description:

  • Purine nucleotide that inhibits viral replication

  Indications:

  • Genital herpes treatment and prophylaxis

  • Mucosal and cutaneous herpes simplex (HSV-1 and HSV-2) treatment and prophylaxis

  • Varicella-zoster (chickenpox & shingles)  

Precautions:

  • Pregnancy category C

  • Dosing modification is required for patients with impaired renal function.

  • Avoid sexual contact when genital lesions are present.

  • Medication treatment is not a cure for viral infection.

  • Do not exceed recommended dose.

  • Initiate therapy at earliest signs of symptoms.

  • Use rubber gloves or a finger cot when applying topical cream to active lesions, so as not to inoculate other areas.

  Adverse Reactions (Side Effects):

  • Malaise (11.5%)

  • Nausea and vomiting (2-8%)

  • Headache (6%)

  • Pain / phlebitis at injection site (9%)

 

 

 

Dosage:

Administered as an oral tablet, capsule, topical cream or injection

Parenteral (avoid rapid IV, IM or SQ injections, administer via slow IV infusion):

Mucosal and cutaneous HSV infections:

  • 5mg/kg infused over 1 hour, every 8 hours for 7 days

Varicella-zoster (shingles) infections:

  • 10mg/kg infused over 1 hour, every 8 hours for 7 days

Herpes simplex encephalitis:

  • 10mg/kg infused over 1 hour, every 8 hours for 10 days

Oral:

Herpes simplex:

  • Initial infection: 200mg q4h (5 times a day) for 10 days

  • Chronic suppression: 400mg bid for 12 months

  • Intermittent therapy: 200mg q4h (5 times a day) for 5 days

Herpes zoster, acute treatment

  • 800mg q4h (5 times a day) for 7-10 days

Chickenpox

  • 20mg/kg (not to exceed 800mg) qid for 5 days

Topical:

  • Apply a sufficient quantity to adequately cover all lesions q3h (6 times a day) for 7 days.

 

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks. Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

OB-GYN 101: Introductory Obstetrics & Gynecology
© 2003, 2004, 2005, 2008 Medical Education Division, Brookside Associates, Ltd.
All rights reserved

 

Advertise on this site